Pharmaceutical companies declare excessive costs are the price of innovation, however the actuality is way extra difficult — and troubling. In 2030, the patents of a few of the world’s best-selling medicine will expire, an occasion referred to as the ‘patent cliff’, and corporations are doubling down on ways akin to ‘evergreening’ patents and pay-for-delay offers to maintain costs excessive and competitors out.
On this video, Neelam Tailor uncovers the stunning methods massive pharma use to sport the system, explaining how these strikes shield earnings however harm sufferers
Supply hyperlink
